Renagel, a new drug to lower serum phosphorus in patients with end-stage renal disease
January 1999
You'll see Renagel, a new drug to lower serum phosphorus in patients with end-stage renal disease.
Renagel (sevelamer) is a polymer that binds and removes phosphates from the GI tract.
It works as well as calcium acetate (PhosLo)...with a lower risk of hypercalcemia and less constipation.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 300+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote